EUCTR2009-016686-28-IT进行中（未招募）不适用
Evaluation of [18F]Fluorocholine PET/CT imaging for staging and restaging of prostate cancer - 18F-FCH
AZIENDA OSPEDALIERA DI PARMA0 个研究点开始时间: 2010年4月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •?Following radical prostatectomy, two consecutive PSA values of 0.2 μg/l and above
- •?Age > 30 years
- •?After initial radiation therapy, three consecutive increasing PSA values above the previous PSA nadir measured at 3-month intervals
- •?Patients with persistently elevated serum levels of prostate-specific antigen (PSA) and negative prostate needle biopsy results
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •?Absence of inclusion criteria
- •?Age < 30 years
- •?PSA level < 0.2 ?g/l in prostate cancer patients after radical prostatectomy or radiotherapy
- •?PSA level < 4 ng/ml in patients with uncertain diagnosis and negative prostate needle biopsy
- •?Extensive calcification in the examination area
- •?Current urinary infection
- •?Not signed Informed Consent
研究者
相似试验
尚未招募
不适用
se of the PET/CT [18F]-Fluorocholine: Diagnostics and Follow-up of Hepatocellular Carcinomahepatocellular carcinomalivercancer1001981510019818NL-OMON36749Academisch Medisch Centrum100
进行中（未招募）
1 期
Prospective comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the initial work-up of Multiple MyelomaMultiple myelomaMedDRA version: 20.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864EUCTR2018-003926-10-FRCHU de Bordeaux30
进行中（未招募）
不适用
study for evaluation of 18F-choline PET/CT efficacy in patients with prostate carcinoma. - NDEUCTR2010-021501-20-ITISTITUTO NEUROLOGICO MEDITERRANEO NEUROMED
进行中（未招募）
1 期
Diagnostic value of 18F-choline PET/CT for the detection of systemic prostate cancer disease. - 2008-CaP-FCHde novo patients with histologically confirmed prostate cancerMedDRA version: 12.0Level: LLTClassification code 10060862Term: Prostate cancerEUCTR2009-014839-21-FRCIS bio international, member of IBA group150
进行中（未招募）
1 期
Role of PET/ CT with 18F-fluorocholine in the staging of patients with intermediate/high risk prostate cancer.EUCTR2013-002511-99-ITISTITUTO ONCOLOGICO VENETO390